HV

Hariprasad Vankayalapati

AP Arrien Pharmaceuticals: 1 patents #1 of 2Top 50%
CO Convergene: 1 patents #1 of 4Top 25%
NA Navigen: 1 patents #1 of 12Top 9%
ST Stingray Therapeutics: 1 patents #1 of 7Top 15%
SO Sumitomo Dainippon Pharma Oncology: 1 patents #7 of 25Top 30%
UU University Of Utah: 1 patents #1 of 12Top 9%
UU University Of Utah: 1 patents #24 of 172Top 15%
📍 Sandy, UT: #6 of 157 inventorsTop 4%
🗺 Utah: #124 of 2,797 inventorsTop 5%
Overall (2020): #36,543 of 565,922Top 7%
5
Patents 2020

Issued Patents 2020

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10849901 Arf6 inhibitors and methods of synthesis and use thereof Kirill Ostanin, Mark Shenderovich, Ashok Bajji, Christopher Cioffi, Neil Moss +1 more 2020-12-01
10752594 JAK1 and ALK2 inhibitors and methods for their use Alexis Henri Abel Mollard, Steven L. Warner, Gary A. Flynn, David J. Bearss 2020-08-25
10717739 Methods and compositions for inhibition of bromodomain-containing proteins Makoto Yoshioka, Jeffrey Strovel, Janak Khimchand Padia 2020-07-21
10689376 Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics Xiaohui Liu, Gurusankar Ramamoorthy, Sunil Sharma, Mohan Kaadige, Alexis Weston +1 more 2020-06-23
10682358 Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis Venkatakrishnareddy Yerramreddy 2020-06-16